SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oncology Report

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2012.1750PMID 22470132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.

  2011cited by this paper
• Tumorigenesis and Neoplastic Progression Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis

  2010cited by this paper
• Silent information regulator, Sirtuin 1, and age‐related diseases

  2009cited by this paper
• SIRT1, Is It a Tumor Promoter or Tumor Suppressor?

  2009cited by this paper
• Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.

  2009cited by this paper
• Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials

  2009cited by this paper
• The critical role of the class III histone deacetylase SIRT1 in cancer.

  2009cited by this paper
• Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

  2009cited by this paper
• New pharmacological strategies against metastatic spread

  2008cited by this paper
• Molecular basis of metastasis.

  2008cited by this paper
• Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.

  2008cited by this paper
• HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α

  2008cited by this paper
• SIRTUIN 1: regulating the regulator.

  2008cited by this paper
• Sirtuins: novel targets for metabolic disease in drug development.

  2008cited by this paper
• Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.

  2008cited by this paper
• A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.

  2008cited by this paper
• SIRT1 controls endothelial angiogenic functions during vascular growth.

  2007cited by this paper
• Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

  2007cited by this paper
• Mediators of vascular remodelling co-opted for sequential steps in lung metastasis

  2007cited by this paper
• Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator

  2007cited by this paper
• Sirtuins: critical regulators at the crossroads between cancer and aging

  2007cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

  2006cited by this paper
• SIRT1: tumor promoter or tumor suppressor?

  2006cited by this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cited by this paper
• Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

  2006cited by this paper
• Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

  2006cited by this paper
• A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer

  2005cited by this paper
• Non-Angiogenic Functions of VEGF in Breast Cancer

  2005cited by this paper
• Calorie restriction, SIRT1 and metabolism: understanding longevity

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• The Sir 2 family of protein deacetylases.

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

  2005cited by this paper
• The Sir2 family of protein deacetylases.

  2004cited by this paper
• Peroxisome proliferator–activated receptor α in the human breast cancer cell lines MCF‐7 and MDA‐MB‐231

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• p53 and vascular‐endothelial‐growth‐factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

  2000cited by this paper
• Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene*

  2000cited by this paper
• The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

  1999cited by this paper
• The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease

  1999cited by this paper
• by two different mechanisms Saccharomyces cerevisiae alone promote longevity in SIR 2 complex and SIR 2 / 3 / 4 The

  1999cited by this paper

• AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity.

  2024cites this paper
• Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism

  2024cites this paper
• A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease.

  2023cites this paper
• Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma

  2023cites this paper
• Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition.

  2023cites this paper
• Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives

  2022cites this paper
• Virtual Screening in the Identification of Sirtuins’ Activity Modulators

  2022cites this paper
• Silent information regulator type-1 mediates amelioration of inflammatory response and oxidative stress in lipopolysaccharide-induced acute respiratory distress syndrome.

  2021cites this paper
• Mangiferin inhibits hypoxia/reoxygenation-induced alveolar epithelial cell injury via the SIRT1/AMPK signaling pathway

  2021cites this paper
• Beneficial Effects on Brain Micro-Environment by Caloric Restriction in Alleviating Neurodegenerative Diseases and Brain Aging

  2021cites this paper
• Sirtuins as NAD+-dependent deacetylases and their potential in medical therapy

  2021cites this paper
• Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1-3 Inhibitors.

  2021cites this paper
• The bifunctional roles of sirtuins and their therapeutic potential in cancer

  2021cites this paper
• Role of Sirtuins in Tumor Angiogenesis

  2020cites this paper
• The sirtuin family in cancer

  2019cites this paper
• SIRT1: a potential tumour biomarker and therapeutic target

  2019cites this paper
• SIRT1 and Ki67 immunohistochemical expression in progression of cutaneous malignant melanoma

  2019cites this paper
• Combating cellular senescence by sirtuins: Implications for atherosclerosis.

  2019cites this paper
• Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype

  2019cites this paper
• SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway

  2018cites this paper
• SIRT1‐ZEB1‐positive feedback promotes epithelial‐mesenchymal transition process and metastasis of osteosarcoma

  2018cites this paper
• SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma

  2018cites this paper
• CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.

  2018cites this paper
• The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

  2018cites this paper
• AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells

  2018cites this paper
• Expression of SIRT1 gene in human lung cancer lines enhances their sensitivity to the anticancer effects of cisplatin.

  2018cites this paper
• The anti-cancer effects and mechanisms of Scutellaria barbata D. Don on CL1-5 lung cancer cells

  2017cites this paper
• SIRT 1 activator , suppresses cell growth , invasion , and migration in gingival epithelial carcinoma cells

  2017influential citation
• CAY10591, a SIRT1 activator, suppresses cell growth, invasion, and migration in gingival epithelial carcinoma cells.

  2017cites this paper
• SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer

  2016cites this paper
• The Impact of Cancer Treatments on Aging

  2016cites this paper
• Sirtuin Activation by Small Molecules

  2016cites this paper
• Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells

  2016cites this paper
• Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

  2016cites this paper
• SIRT1 promotes metastasis of human osteosarcoma cells

  2016cites this paper
• Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians

  2016cites this paper
• Quantitative Analysis of the Proteomic Response of Human Tumor Cell Lines to Sirtinol

  2015cites this paper
• Silencing Angiopoietin‐Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide‐Induced Acute Lung Injury Via Regulating SIRT1 /NF‐kB Pathway

  2015cites this paper
• Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.

  2015cites this paper
• Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer

  2015cites this paper
• SIRT1 expression is associated with poor prognosis of lung adenocarcinoma

  2015cites this paper
• The multifaceted functions of sirtuins in cancer

  2015cites this paper
• Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.

  2015cites this paper
• SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway

  2015cites this paper
• Small molecule SIRT1 activators for the treatment of aging and age-related diseases.

  2014cites this paper
• Small molecule SIRT 1 activators for the treatment of aging and age-related diseases

  2014cites this paper
• Identification of a novel polyprenylated acylphloroglucinol-derived SIRT1 inhibitor with cancer-specific anti-proliferative and invasion-suppressing activities

  2014cites this paper
• Cancer Biology and Signal Transduction Inhibition of SIRT 1 Signaling Sensitizes the Antitumor Activity of Silybin against Human Lung Adenocarcinoma Cells In Vitro and In Vivo

  2014cites this paper
• SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

  2014cites this paper
• Sirtuin1 Over-Expression Does Not Impact Retinal Vascular and Neuronal Degeneration in a Mouse Model of Oxygen-Induced Retinopathy

  2014cites this paper
• Dietary energy balance modulates ovarian cancer progression and metastasis

  2014cites this paper
• Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer

  2014influential citation
• Modulation of Tumorigenesis by Dietary Intervention Is Not Mediated by SIRT1 Catalytic Activity

  2014cites this paper
• Inhibition of SIRT1 Signaling Sensitizes the Antitumor Activity of Silybin against Human Lung Adenocarcinoma Cells In Vitro and In Vivo

  2014cites this paper
• Coumestrol induces mitochondrial biogenesis by activating Sirt1 in cultured skeletal muscle cells.

  2014cites this paper
• The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet.

  2014cites this paper
• SRT 1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

  2014cites this paper
• Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis

  2014cites this paper
• SIRT 1 Inactivation Evokes Antitumor Activities in NSCLC through the Tumor Suppressor p 27

  2014cites this paper
• SIRT1 Inactivation Evokes Antitumor Activities in NSCLC through the Tumor Suppressor p27

  2014cites this paper
• Seven sirtuins for seven deadly diseases of aging.

  2013cites this paper
• Calorie Restriction and Cancer Prevention: Established and Emerging Mechanisms

  2013cites this paper
• SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.

  2013cites this paper
• Search for a novel SIRT1 activator: structural modification of SRT1720 and biological evaluation.

  2013cites this paper
• Sirtuin 1 Over-Expression Does Not Impact Retinal Vascular and Neuronal Degeneration in a Mouse Model of Oxygen-Induced Retinopathy

  2013cites this paper
• Calorie restriction and cancer prevention: a mechanistic perspective

  2013cites this paper
• SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC

  2013cites this paper
• SIRT1 Catalytic Activity Has Little Effect on Tumor Formation and Metastases in a Mouse Model of Breast Cancer

  2013cites this paper
• The emerging and diverse roles of sirtuins in cancer: a clinical perspective

  2013cites this paper
• The emerging and diverse roles of sirtuins in cancer: a clinical perspective

  2013cites this paper
• The sirtuin family's role in aging and age-associated pathologies.

  2013cites this paper
• SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK

  2013cites this paper
• SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.

  2013cites this paper